PBPK Modelling for Drugs Cleared by Non-CYP Enzymes: State-of-the-Art and Future Perspectives.
Saved in:
| Title: | PBPK Modelling for Drugs Cleared by Non-CYP Enzymes: State-of-the-Art and Future Perspectives. |
|---|---|
| Authors: | Ozbey AC; Roche Pharma Research and Early Development, F.Hoffmann-La Roche, Switzerland neil_john.parrott@roche.com., Fowler S; Drug Metabolism, F. Hoffmann-La Roche Ltd, Switzerland., Leys K; Drug Delivery and Disposition Lab, Department of Pharmaceutical and Pharmacological, KU Leuven University, Belgium., Annaert P; Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium., Umehara K; Pharmaceutical Sciences, Roche Pharmaceutical Research and Early Development, Switzerland., Parrott N; Roche, Switzerland neil_john.parrott@roche.com. |
| Source: | Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2023 Oct 25; Vol. 52 (1). Date of Electronic Publication: 2023 Oct 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
